|
|
||||||||
Original Report |
1 Both authors: Department of Radiology, Palo Alto Medical Clinic, 795 El Camino Real, Palo Alto, CA 94301
OBJECTIVE. The purpose of our study was to evaluate how often a mammographic abnormality thought to be produced by the biopsy procedure was evident on the initial follow-up mammogram after percutaneous biopsy of impalpable histologically benign lesions. We compared three stereotactic percutaneous biopsy methods.
CONCLUSION. A mammographic density seen well only in the projection parallel to the biopsy needle tract was evident in 2% (5/226) of the lesions for which 11-gauge directional vacuum-assisted biopsy was used, 0% (0/96) of the lesions for which 14-gauge directional vacuum-assisted biopsy was used, and 0% (0/422) of the lesions for which 14-gauge automated large-core biopsy was used. No mammographic abnormalities assessed as BI-RADS categories 3, 4, or 5 (according to the American College of Radiology's Breast Imaging Reporting and Data System) and thought to be produced by the biopsy procedure were evident after any of the biopsy methods.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. A. Guenin, M. L. R. Darling, D. N. Smith, and S. C. Lester Less Is Not More in Stereotactic Biopsy Am. J. Roentgenol., July 1, 2001; 177(1): 250 - 251. [Full Text] [PDF] |
||||
![]() |
W. A. Berg, C. L. Arnoldus, E. Teferra, and M. Bhargavan Biopsy of Amorphous Breast Calcifications: Pathologic Outcome and Yield at Stereotactic Biopsy Radiology, November 1, 2001; 221(2): 495 - 503. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |